Cargando…
Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches
The United States is in the midst of an opioid addiction and overdose crisis precipitated and exacerbated by use of prescription opioid medicines. The majority of opioid prescriptions are dispensed to patients with comorbid mood disorders including major depressive disorder (MDD). A growing body of...
Autores principales: | Peciña, Marta, Karp, Jordan F., Mathew, Sanjay, Todtenkopf, Mark S., Ehrich, Elliot W., Zubieta, Jon-Kar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310672/ https://www.ncbi.nlm.nih.gov/pubmed/29955162 http://dx.doi.org/10.1038/s41380-018-0117-2 |
Ejemplares similares
-
Risk for opioid misuse in chronic pain patients is associated with endogenous opioid system dysregulation
por: Ballester, Javier, et al.
Publicado: (2022) -
Molecular Mechanisms of Placebo Responses In Humans
por: Peciña, Marta, et al.
Publicado: (2014) -
Positron emission tomography imaging of endogenous mu-opioid mechanisms during pain and migraine
por: DaSilva, Alexandre F., et al.
Publicado: (2019) -
Effects of placebo administration on immune mechanisms and relationships with central endogenous opioid neurotransmission
por: Prossin, Alan, et al.
Publicado: (2021) -
Mindfulness-Oriented Recovery Enhancement remediates hedonic dysregulation in opioid users: Neural and affective evidence of target engagement
por: Garland, Eric L., et al.
Publicado: (2019)